The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin In The Treatment And Secondary Prevention Of Acute Venous Thromboembolism In The Uk
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1442
https://www.valueinhealthjournal.com/article/S1098-3015(14)03372-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
923
First Page :
A489
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03372-5&doi=10.1016/j.jval.2014.08.1442